KORTUC INC., founded in 2015, is a trailblazer in the Biotechnology, Health Care, and Pharmaceutical industries. The company is headquartered in the United States and is renowned for its innovative approach to enhancing the efficacy of cancer treatments.
With its slogan, "Revolutionizing Cancer Radiotherapy by the cutting-edge technology from Japan," KORTUC INC. introduces a groundbreaking drug that utilizes Hydrogen Peroxide injections into tumors. This method significantly elevates the sensitivity of tumors to radiotherapy, addressing the fundamental challenge of making radiotherapy more potent and effective.
The company's potential was acknowledged through a substantial $21.00M Series A investment completed on 01 May 2021. This underscores investor confidence and provides a solid foundation for further development and market penetration.